Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valens Company Inc (The) Ordinary Shares VLNS


Primary Symbol: VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada and other countries, and it generates a majority of revenue from the Cannabis operations segment.


OTCQX:VLNCF - Post by User

Valens Company Inc (The) Ordinary Shares > Valens Company Sources $40.0 Million Term Loan To Fund Growt
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(630)
•••
Comment by SIMPLICITI1on Dec 16, 2021 9:11am
63 Views
Post# 34236116

RE:Valens Company Sources $40.0 Million Term Loan To Fund Growt

RE:Valens Company Sources $40.0 Million Term Loan To Fund GrowtWell, if "To Fund Growth" means cash to support the ever expanding burn rate and past purchase obligations, then I guess its better than selling paper at these levels.

My guess is the new forecasts for the expanded enterprise are lower than they were when acquisitions were made. Ouch! 

Wish and a Prayer Management.






<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities